Literature DB >> 19636669

Senescent endothelial progenitor cells from dogs with pulmonary arterial hypertension: a before-after self-controlled study.

Liang Xia1, Jun-hui Zhu, Fu-yu Qiu, Ying Yang, Xu-dong Xie, Xing-xiang Wang, Jun-zhu Chen, Guo-sheng Fu.   

Abstract

Previous studies have underlined the importance of endothelial dysfunction and microvascular occlusion in the pathogenesis of pulmonary artery hypertension (PAH). Since the endothelial progenitor cells (EPCs) are involved in maintaining endothelial homeostasis, we observed the change of peripheral EPCs in canines before and after PAH onset. PAH was induced by intra-pulmonary artery injection of dehydromonocrotaline (DHMC) in nine beagles. Before and 48 h and 6 weeks after DHMC injection, 40 ml peripheral blood was obtained from the femoral vein. Circulating EPCs were identified as CD133 + KDR + cells and numerated by fluorescence-activated cell sorter; the EPCs functional capacity was determined by in vitro tubule-forming assay. The senescence of EPCs was determined by beta-galactosidase staining. At each time point, 2 ml blood from femoral artery was obtained for arterial oxygen pressure (PaO(2)). Forty-eight hours after DHMC injection, treated beagles suffered from hypoxemia; however, both the number and the tubule-forming capacity of EPCs were transiently raised. Six weeks later, PAH was confirmed by obviously high mean pulmonary arterial pressure (20.2 +/- 1.64 vs. 11.3 +/- 2.0 mmHg, p < 0.05) and low PaO(2) (69.30 +/- 9.15 vs. 95.94 +/- 1.43 mmHg, p < 0.01) in beagles after DHMC treatment, and their EPCs exhibited a predominant decrease in either the number (206.1 +/- 26.8 vs. 632.8 +/- 42.8 cells/ml blood, p < 0.01) or the tubule-forming capacity (21.1 +/- 2.8 vs. 11.2 +/- 2.8 tubules/x200 field, p < 0.01). Additionally, senescence-associated beta-galactosidase-positive EPCs were significantly increased. Our data suggested that, after the acute stage of DHMC injury to pulmonary vessels, the EPCs from PAH beagles suffered from exhaustion and senescence.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19636669     DOI: 10.1007/s12576-009-0053-7

Source DB:  PubMed          Journal:  J Physiol Sci        ISSN: 1880-6546            Impact factor:   2.781


  35 in total

1.  Circulating endothelial precursors: mystery, reality, and promise.

Authors:  S Rafii
Journal:  J Clin Invest       Date:  2000-01       Impact factor: 14.808

Review 2.  Endothelial progenitor cells: new hope for a broken heart.

Authors:  Paul E Szmitko; Paul W M Fedak; Richard D Weisel; Duncan J Stewart; Michael J B Kutryk; Subodh Verma
Journal:  Circulation       Date:  2003-06-24       Impact factor: 29.690

3.  Endothelial cell dysfunction correlates differentially with survival in primary and secondary pulmonary hypertension.

Authors:  A A Lopes; N Y Maeda; R C Gonçalves; S P Bydlowski
Journal:  Am Heart J       Date:  2000-04       Impact factor: 4.749

4.  HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes.

Authors:  Birgit Assmus; Carmen Urbich; Alexandra Aicher; Wolf K Hofmann; Judith Haendeler; Lothar Rössig; Ioakim Spyridopoulos; Andreas M Zeiher; Stefanie Dimmeler
Journal:  Circ Res       Date:  2003-04-03       Impact factor: 17.367

5.  Vascular remodeling in experimentally induced subacute canine pulmonary hypertension.

Authors:  R Gust; D P Schuster
Journal:  Exp Lung Res       Date:  2001 Jan - Feb       Impact factor: 2.459

6.  Trapping and measurement of short-lived alkylating agents in a recirculating flow system.

Authors:  A R Mattocks; R Jukes
Journal:  Chem Biol Interact       Date:  1990       Impact factor: 5.192

7.  Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: efficacy of combined cell and eNOS gene therapy in established disease.

Authors:  Yidan D Zhao; David W Courtman; Yupu Deng; Lakshmi Kugathasan; Qiuwang Zhang; Duncan J Stewart
Journal:  Circ Res       Date:  2005-02-03       Impact factor: 17.367

Review 8.  Primary pulmonary hypertension.

Authors:  James R Runo; James E Loyd
Journal:  Lancet       Date:  2003-05-03       Impact factor: 79.321

9.  Circulating von Willebrand factor antigen as a predictor of short-term prognosis in pulmonary hypertension.

Authors:  A A Lopes; N Y Maeda
Journal:  Chest       Date:  1998-11       Impact factor: 9.410

10.  Simple procedures for preparing putative toxic metabolites of pyrrolizidine alkaloids.

Authors:  A R Mattocks; R Jukes; J Brown
Journal:  Toxicon       Date:  1989       Impact factor: 3.033

View more
  7 in total

Review 1.  Mechanisms of dysfunction in senescent pulmonary endothelium.

Authors:  Daniel Jane-Wit; Hyung J Chun
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-03-05       Impact factor: 6.053

2.  Pluripotent hematopoietic stem cells augment α-adrenergic receptor-mediated contraction of pulmonary artery and contribute to the pathogenesis of pulmonary hypertension.

Authors:  Ryota Hashimoto; Gregg M Lanier; Vidhi Dhagia; Sachindra R Joshi; Allan Jordan; Ian Waddell; Rubin Tuder; Kurt R Stenmark; Michael S Wolin; Ivan F McMurtry; Sachin A Gupte
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-01-08       Impact factor: 5.464

3.  Hypoxia does neither stimulate pulmonary artery endothelial cell proliferation in mice and rats with pulmonary hypertension and vascular remodeling nor in human pulmonary artery endothelial cells.

Authors:  Lunyin Yu; Charles A Hales
Journal:  J Vasc Res       Date:  2011-06-17       Impact factor: 1.934

Review 4.  Endothelial Senescence: A New Age in Pulmonary Hypertension.

Authors:  Miranda K Culley; Stephen Y Chan
Journal:  Circ Res       Date:  2022-03-17       Impact factor: 17.367

5.  The synergistic therapeutic effect of hepatocyte growth factor and granulocyte colony-stimulating factor on pulmonary hypertension in rats.

Authors:  Yinghua Guo; Longxiang Su; Yinghui Li; Na Guo; Lixin Xie; Dong Zhang; Xiaojun Zhang; Hongxia Li; Guizhi Zhang; Yajuan Wang; Changting Liu
Journal:  Heart Vessels       Date:  2013-08-10       Impact factor: 2.037

6.  Cyp2c44-mediated decrease of 15-HETE exacerbates pulmonary hypertension.

Authors:  Gábor Á Fülöp; Andriy Yabluchanskiy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-06-16       Impact factor: 5.125

7.  Monoclonal Antibodies 13A4 and AC133 Do Not Recognize the Canine Ortholog of Mouse and Human Stem Cell Antigen Prominin-1 (CD133).

Authors:  Kristina Thamm; Sylvi Graupner; Carsten Werner; Wieland B Huttner; Denis Corbeil
Journal:  PLoS One       Date:  2016-10-04       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.